Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
National Institutes of Health (NIH)
Maximum funding amount: $300,000 per year
Maximum project duration: 4 years
To conduct time-sensitive ancillary studies related to the NIAMS mission in conjunction with ongoing clinical projects.
Research community, patients involved in clinical studies, and organizations conducting clinical research.
NIH funding source
Grant funding type
Recurring grant opportunity
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
U.S. organizations are eligible; foreign organizations are not eligible.
Encourages collaboration between basic and clinical investigators.
Enhancing scientific content of ongoing clinical projects.
Identify novel targets for diagnosis, treatment, and prevention of disease.
Applications must demonstrate scientific merit and feasibility.
Budgets for direct costs are limited up to $300,000 per year.
Latest submission deadline: December 5, 2025.
Must comply with NIH Grants Policy Statement.
Applications must include a letter of support from the parent study leadership committee.